Clorox CLX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $824M+182% | $292M+81.4% | $161M-65.8% | $471M-34.5% | ||
| $219M-6.8% | $235M-0.4% | $236M+5.4% | $224M+6.2% | ||
| $81M+9.5% | $74M+1.4% | $73M+40.4% | $52M0.0% | ||
| —— | —— | -$149M— | —— | ||
| -$63M— | —— | -$58M— | —— | ||
| —— | —— | $157M— | —— | ||
| —— | -$25M— | —— | -$16M-152% | ||
| $26M+200% | -$26M+36.6% | -$41M— | —— | ||
| $2M+101% | -$147M-197% | $152M— | —— | ||
| $145M+326% | $34M+162% | $13M-84.5% | $84M— | ||
| $981M+41.2% | $695M-40.0% | $1.16B+47.3% | $786M-38.4% | ||
| $220M+3.8% | $212M-7.0% | $228M-9.2% | $251M-24.2% | ||
| —— | $17M— | —— | $0— | ||
| $2M— | —— | -$5M+77.3% | -$22M-161% | ||
| -$94M+46.3% | -$175M+21.5% | -$223M+2.6% | -$229M+49.3% | ||
| $602M+1.2% | $595M+2.1% | $583M+2.1% | $571M+2.3% | ||
| $332M— | $0— | $0— | —— | ||
| $16M— | —— | —— | —— | ||
| $0— | —— | -$188M— | —— | ||
| -$924M-41.1% | -$655M+13.0% | -$753M-9.3% | -$689M+50.5% | ||
| $0+100% | -$26M— | $0— | —— | ||
| -$37M+77.0% | -$161M-188% | $182M— | —— | ||
| $97M-4.9% | $102M+3.0% | $99M+11.2% | $89M0.0% | ||
| $264M-23.9% | $347M+375% | $73M-27.0% | $100M-67.0% | ||
| —— | -$238M— | —— | $0— | ||
| $2M+101% | -$147M-197% | $152M— | —— | ||
| —— | -$25M— | —— | -$16M-152% | ||
| $2M— | $0— | —— | -$1M+50.0% | ||
| $26M+200% | -$26M+36.6% | -$41M— | —— | ||
| $2M— | —— | -$5M+77.3% | -$22M-161% | ||
| —— | $17M— | —— | $0— | ||
| —— | —— | $33M+560% | $5M-95.1% | ||
| $0— | —— | -$188M— | —— | ||
| $264M-23.9% | $347M+375% | $73M-27.0% | $100M-67.0% | ||
| $761M+57.6% | $483M-48.1% | $930M+73.8% | $535M-43.4% | ||
| $761M+57.6% | $483M-48.1% | $930M+73.8% | $535M-43.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Clorox's cash flow data come from?
- Every line is extracted from Clorox's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
